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Introduction:
In this project we studied special challenges faced by elderly patients with diabetes and evaluated ways to help patients overcome these barriers.
Diabetes Mellitus is a major public health problem affecting an increasing number of older individuals. Burdened with additional medical, functional, and psychosocial issues, many older adults struggle to follow their diabetes treatment regimen. When the same criteria and strategies to manage diabetes in young adults are applied to the elderly without considering their special circumstances, there is an increased risk of 1) noncompliance 2) complications of treatment e.g. hypoglycemia or falls, and 3) poor glycemic control leading to complications.
In this study, we evaluated whether short-term focused intervention by a geriatric multidisciplinary team with the addition of a geriatric life specialist is superior to usual care (with attention control) in improving glycemic, functional, economic and quality of life parameters in elderly patients with diabetes, and whether these interventions have persistent effects on outcome measures. In addition, we also assessed changes in cerebral perfusion in elderly with type 2 diabetes following six months intervention and assess whether changes in cerebral perfusion persist at a one-year follow up. We recruited patients over age 70 with diabetes and randomized them to care by either geriatric diabetes intervention team (GDT) or attention control group. Subjects in GDT group had comprehensive geriatric assessment and have individualized intervention performed with help of a geriatric life specialist. Intervention by GDT included focused strategies to overcome barriers in the areas of clinical care, education, social environment, and finances. At the end of 6 months of intervention, the goal was to develop a support network that may empower patients to sustain improvements seen during the intervention. After 6 months of independence period (no contact from GDT), outcome parameters were measured again to see if improvement at 6 months was sustained after 12 months. The subjects in the control group had similar contact time as the GDT group, but with a research team without geriatric expertise. Improvement in clinical, functional, quality of life and economical outcome measures in both groups were compared at 6 and 12 months intervals. At these time points (0, 6 and 12 months) patients were also evaluated for effect of improved glycemic control on cerebral perfusion and glycemic excursions. Over the first 0-6 months of the study, we developed detailed project procedures and recruited and trained various personnel including research assistant, diabetes educator, nutritionist, and geriatric life specialist. At the same time, all the institutional approvals were obtained which took longer than expected as we had to go through 2 committees on human studies; at the Joslin Diabetes Center as well as at the Beth Israel Deaconess Medical Center (BIDMC).
We then worked with Human Research Protection office (HRPO) at the USAMRMC, to modify our protocol for compliance with applicable federal, DOD, and Army human subjects protection regulations. As per the suggestions by the Human Subject Protection Scientist at the HRPO, we designed detailed protocol procedures for the intervention group as well as attention control group. We designed telephone dialogue scripts, brochures and fliers for the study recruitment process. We also modified the protocol, consent forms and assent form as recommended. We described, developed and/or modified many of the outcome measurement tools for clinical, functional and psychosocial parameters. Simultaneously, we developed database with forms and data management tools.
Identification of study subjects from electronic medical records and recruitment (Mos. As mentioned above, our recruitment started a little later than expected in the third quarter of the study due to lengthy approval process that we needed to go through. Once the approvals were received, we initially focused our attention on the Joslin clinic population. We have an excellent system to identify eligible subject from medical records at the Joslin diabetes center. We called/screened numerous eligible patients. However, recruitment during winter season in Massachusetts was difficult. Frequent inclement weather caused many study visit cancellations in the elderly patients with diabetes, also affecting accrual to the study. To modify this situation, and to increase our recruitment pool, we submitted our study protocol for approval at the Beth Israel Deaconess Medical Center. We received approval from the human subject protection committee at BIDMC, and submitted the protocol changes to the HPRO at the USAMRMC. Besides adding this center to improve enrollment, we have also encouraged different ways to facilitate transportation in elderly patients. These measures improved enrollment.
At the end of the study, we have recruited total of 100 older patients with diabetes; 16 patients in the control group and 35 patients in the geriatric life specialist intervention group for this study. Additionally, we have studied 49 more subjects for a parallel study. Thus our final analysis includes 30 patients in the control group, 35 patients in the geriatric life specialist intervention group and 35 patients with similar intervention without geriatric life specialist.
Task 2: Baseline assessment (Mos. 4-36): at Joslin Clinic
We have collectedextensive data in our clinical and functional assessment at baseline. Following surveys and tools were completed at the baseline, at 6-months and at 12-months visits: In addition, in the second year of the study, based on our experience with the study subjects and based on the recent publication of an article, we added continuous glucose monitoring to our protocol for assessment of glucose excursion in older patients. We renegotiated the budget and applied and receive regulatory approvals from all institutional entities. This provided very important data not available in literature for better diabetes care in older adults and has already resulted in publication.
As we collected baseline data, we performed cross-sectional interim analysis and submitted abstracts to the scientific meetings of the American Diabetes Association over last 3 years. They were presented at the meeting as posters and oral presentations. The abstracts showing baseline data are as follows.
Results:

Higher Exercise Capacity in Older Adults with Diabetes is Associated with
Better Self-Care Ability and Less Diabetes-Related Stress. In: 69 th annual meeting of the American Diabetes Association; New Orleans La; 2009. 367-OR Diabetes in older adults is associated with multiple co-existing medical conditions that increase the overall burden of self-care and affect quality of life. Exercise is an integral part of diabetes management for all patients but its effect on self-care ability and diabetes related stress in older adults is not well studied. Methods: Community-living adults >70 years, A1c>8%, were enrolled in a study to identify geriatric-specific barriers to diabetes management. Exercise capacity was tested using the 6-Minute Walk Test (6MWT). Self-care ability and diabetes-related stress were evaluated using Self-Care Inventory (SCI) and Problem Areas in Diabetes (PAID) questionnaires respectively. Subjects were also assessed for cognitive dysfunction, depression, and glycemic control (A1c).
Results: Forty-five subjects (age 76±5 years, diabetes duration 22±10 years) were divided into 2 groups based on distance walked during 6MWT at median value (313 meters). Subjects with higher exercise capacity tended to be male (77% vs 48%, p<0.05), Caucasian (91% vs 50%, p<0.002), and had lower BMI (31±6 vs 35±9, p<0.04). This group scored higher on SCI (67±9 vs 56±14, p<0.003) suggesting better self-care abilities and lower on PAID (18±10 vs 30±16, p<0.006) reflecting less diabetes related stress, compared to subjects with lower exercise capacity. Depressive symptoms (measured by Geriatric Depression scalre) were present in 18% of the subjects in the lower exercise capacity group as compared to none in high scoring group (p<0.03). Groups did not differ with respect to A1c and measures of cognitive function. However, the higher exercise group had better gait and balance (Tinnetti score 26±2 vs 22±7, p<0.004) and was more likely to be independent in performing activities of daily living (IADL score 16± 0.8 vs 14±3, p<0.04). Conclusions: Higher exercise capacity is associated with better self-care ability, less depression, less diabetes-related stress and better performance of daily tasks. Exercise education should be stressed in older adults with diabetes to maintain functional independence and optimize quality of life. In older adults with diabetes, hypoglycemia is the most important factor limiting efforts to improve glycemic control. The efforts to avoid hypoglycemia may lead to poor glycemic control in these patients. Occurrence and frequency of episodes of hypoglycemia in this population with inadequate glycemic control remains unknown. Methods: Patients >70 years of age with poor glycemic control (A1c>8%), enrolled in a study to identify barriers to diabetes management were evaluated for hypoglycemic events. A detailed questionnaire was administered to characterize hypoglycemia. Demographic information and clinical data were collected by surveys. All of the subjects underwent testing for cognitive function, depression, and functionality. Results: We evaluated 45 patients with average age 75±5 years, duration of diabetes 22±10 years, and A1c 9.1±0.5%. Over 90% patents were receiving insulin in this group. Despite poor glycemic control, 42 of 45 patients reported episodes of hypoglycemia within past 3 months. Eighteen of forty-two (43%) subjects had frequency of more than few episodes a month, while 57% had rare episodes. Cognitive dysfunction was identified in 28% patients with high frequency and 33% patients with low frequency of hypoglycemia (p=NS) suggesting possibility of under-reporting of this condition. In patients with higher frequency of hypoglycemia A1c was lower (8.8±.5 vs 9.5± 1; p<0.01) suggesting wide glycemic excursions. Although typical hypoglycemic symptoms such as shakiness (56%) and sweating (51%) were frequently reported, atypical symptoms such as weakness (31%), hunger (31%), change in behavior (16%) dizziness (16%), and vision changes (18%) were also common, and can be missed if not asked for specifically. Twenty four (53%) patients continued to drive but only 11 (24%) patients checked blood glucose before driving. Only 36% patients with hypoglycemia reported fear of hypoglycemia. Hypoglycemia should be carefully looked for even with poor glycemic control in the older population. Improvement of glycemic control may require improving wide glucose excursions in this population.
The risk of hypoglycemia is a treatment-limiting factor in older adults
Inadequate social resources is associated with increased clinical, functional
and economic burden in older adults. In: 69 th annual meeting of the American Diabetes Association; New Orleans La; 2009; 1870-P.
Managing diabetes in older adults is complicated by co-existing medical, functional and psychosocial issues. The effect of the availability of social resources on these aspects in older adults with diabetes in not well studied Methods: We evaluated patients >70 years age with poor glycemic control (A1C>8%) enrolled in a study to assess the barriers to diabetes management for the effect of available social resources on clinical, functional and economic burden. Social resources were assessed by OARS (Older American Resource and Services), a tool developed by the Duke OARS program to assess the availability of physical and emotional resources. A maximum score of 14 reflected excellent availability of social resources. The subjects were divided in to low vs high resources groups at the mean OARS score of 12. All of the subjects were tested for cognitive dysfunction, depression, and functionality. Data on overall health and health services utilization were collected by administering questionnaires. Results: Forty-five patients with diabetes were evaluated. Eighteen of 45 (40%) subjects had a low score on OARS compared to 27/45 (60%) with high score. Age was similar in both groups (76± 6 vs 76±4 years). Compared to subjects in the high resource group, low social resource group tended to be female (83% vs 48%, p<0.01), had longer duration of diabetes (25 vs 18 years, p<0.03) and lived alone (56% vs 19%, p<.009). In addition, the group with low social resources had higher A1c (9.4±1.2 vs 8.9±0.5, p<0.05) indicating poor glycemic control, lower exercise capacity as measured by lower socre on 6 minutes walk test (235 vs 364 meters), and higher number of ER visits in past 3 months (44% vs 15%, p<0.04) suggesting higher healthcare costs, compared to the higher social support group. There was no difference between the 2 groups in the areas of cognitive function, depression, stress related to diabetes management or self-care abilities Conclusions: In older adults with diabetes, inadequate social resources are associated with poor glycemic control, lower functionality and higher health care cost. It is important to assess individual older adults' resources while providing management plans.
Task 3: Team assessment and active intervention b y Geriatric care ambassador (geriatric life specialist (GLS) (mos. 4-42) at Joslin Clinic
Each patient in the intervention group underwent multidisciplinary assessment by the team consisting of a geriatric diabetologist, a nurse educator and a nutritionist. The list of assessments (Table 1 ) and the interventions recommended (Table 2 ) are shown below.
Barrier Assessment
In Co-existing medical conditions such as cognitive dysfunction and vision/hearing problems are common in older adults and may interfere with their ability to perform selfcare. Insulin injections pose a particularly difficult problem. Methods: As part of an ongoing study to assess barriers to diabetes management in older adults, an in-depth diabetes self-management assessment was conducted on 27 community living older adults (age 76.45.1 years, duration of diabetes 17.89.1 years). Twenty-two of 27 (81.4 %) subjects were on insulin. Study participants on insulin were questioned about their insulin use and observed drawing or dialing up their insulin doses. Results: When interviewed, none of the participants reported any trouble taking their insulin, however, when observed by a certified diabetes educator, 12/22 insulin users (54%), with long duration of insulin use (average 13.1 years) were found to have difficulty with technique or dosing. Problems with technique included difficulty seeing the lines on the syringe, mixing the insulin correctly, seeing air in the syringe and inability to follow the steps correctly. Problems with dosing included taking too much or too little, not understanding regimen, and reports of omitting insulin. The group having trouble with insulin technique and dosing were more likely to miss doses of other medications (p=0.009) suggesting overall problems with adherence, and were having trouble reading food labels (p=0.05) suggesting possible problems with health literacy. Higher frequency of falls, fear of falls, and difficulty walking were more common in the group having problems taking insulin, however, these parameters did not reach statistical significance. There were no differences between the two groups in areas of glycemic control (A1c 9.5 vs 9.1%), vision, cognitive function, depression, or diabetes related stress. Conclusions: Observing insulin technique periodically should be an important part of the diabetes assessment in older adults even with a long duration of insulin use. Assessment of co-existing medical condition should be integrated in education regarding insulin injections. Burdened with medical and functional co-morbidities, older adults with diabetes struggle to achieve glycemic control, often resulting in increased risk of hypoglycemia. Episodes of hypoglycemia are particularly dangerous in the older population. To reduce the risk of hypoglycemia, relaxation of the standard A1c goal to <8% has been proposed for the frail elderly. However, the effectiveness of this recommendation in reducing hypoglycemia is unknown. Methods: We evaluated community-living adults age >70 years, with A1c>8%, for episodes of hypoglycemia. We used blinded continuous glucose monitoring (CGM) for at least 72 consecutive hours. Patients performed finger-stick monitoring 4 times a day during CGM use and documented symptoms suggestive of hypoglycemia. Results: CGM was performed on 33 adults for a mean duration of 87.7 hours. Mean age of the population was 75.24.6 years, duration of diabetes 18.611 years, and A1c 9.41.3%. Seventy-seven percent of patients had type 2 diabetes and 91% were using insulin. At least 1 episode of hypoglycemia (glucose <70 mg/dl) per CGM period was observed in 20 patients (61%), with mean glucose level of 616.2 mg/dl during the episode. The average number of hypoglycemic episodes was 3.85/patient and average duration was 53 minutes/episode. Eighty percent of patients with hypoglycemia (16/20) suffered at least 1 nocturnal episode (between 10 pm-6 am), with average duration of 52.5 minutes/episode. Out of a total of 77 hypoglycemic episodes, 73 (95%) were unrecognized (not captured by either finger-stick monitoring or by subjective symptoms). All patients with hypoglycemia had at least 1 unrecognized hypoglycemic episode. Only 1/32 nocturnal episodes was recognized by patients. Fifty percent (10/20) of the patients with hypoglycemia had an A1c >9% and 60% (6/10) of these patients had nocturnal hypoglycemic episodes. Conclusions: We conclude that hypoglycemia, especially unrecognized hypoglycemia, is common in older adults, even in those with high A1c levels. This suggests that simply relaxing the standard A1c goal to <8% will not be sufficient to reduce the incidence of hypoglycemia to an acceptable safe level for the frail elderly population with diabetes. During the study, we identified continuous glucose monitoring (CGM) as a tool for pattern identification and for recognizing hypoglycemia in this elderly population. We asked for an addendum to the protocol to perform CGM at baseline, 6-months and 12-months. We received approval from all institution approval committees. This assessment has already resulted in a publication in the prestigious journal "The Archives of Internal Medicine".
We have 99 % completion rate for 6-month assessment for the glycemic control. Older adults with diabetes with poor control are a very frail and vulnerable population and there are many challenges to performing 12-months longitudinal study on that population. Some patients could not complete functional and psychosocial assessment tools at 6-months due to illnesses. We believe that our diligent follow-up resulted in excellent completion rate in this difficult population.
Our interim data analysis was presented at the scientific meeting of the American Diabetes Association.
Self-management interventions to overcome barriers to diabetes care in older adults:
A randomized controlled study. 70 th annual meeting of the American Diabetes Association; Orlando FL; 2010. 0716-P Older adults with diabetes face adverse clinical, functional and psychosocial challenges to diabetes self-management. We performed a randomized controlled study to assess whether geriatric-specific intervention strategies can help older adults achieve better glycemic control and improve ability to perform self-care. Methods: We randomized adults 70 years age with diabetes for 1 year, with A1C>8%, to either an intervention or a control group. After baseline assessment of outcome measures, the intervention group had geriatric team evaluation and interventions to optimize their ability to follow diabetes treatment regimen. The attention control group received equivalent time from a separate research staff. Diabetes providers followed all patients for medication management. All patients underwent clinical [A1c, body mass index (BMI)], functional [Instrumental activities of daily living (IADL), and Tinneti Test for gait and balance)], and psychosocial [self-care abilities (Self Care Inventoryrevised (SCI)) and diabetes-related distress (Problem Areas in Diabetes (PAID))] assessments at baseline and 6 months. Results: To date, 58/90 (64%) of the patients (average age 765 years, diabetes duration 2112 years, A1c 9.21.1%, BMI 337, 71% type 2, and 93% on insulin therapy) completed 6 months intervention. The most common barriers found were need for diet counseling (88%), medication adjustment (85%) and inadequate exercise (60%). The most common interventions were referral to nutritionist (90%), referral to educator (88%) and earlier appointment with medical provider for medication adjustment (68%). As shown in the table, the intervention arm improved on Tinneti, SCI, PAID, BMI and A1c, while IADL deteriorated in the control arm. Conclusion: Focused geriatric specific interventions improve diabetes management capability in older adults.
Change from baseline to 6 months All the subjects, who were randomized to the intervention arm of the study, were given an option to sign a separate consent form for a cerebral blood flow study performed at the SAFE lab at BIDMC as per part B of the protocol. Out of 35 patients assigned to this intervention, 21 completed part B of the protocol at the baseline. Nine patients refused to sign the consent form for this additional assessment. Three patients did not have an open portal to perform vascular ultrasound. Three patients refused to undergo the test after they went to the SAFE lab and saw the testing done. Thirteen patients completed testing twice and eight patients completes all 3 times. Some subjects could not complete all the components of the study due to uncomfortable feeling and the study procedure was stopped per protocol. All the other subjects have tolerated the study procedure well.
We evaluated cerebral blood flow responses to intervention using a protocol with simultaneous beat-to-beat measurements of cardiovascular parameters and cerebral blood flow velocities at baseline and during head tilt. Vascular reserve was tested using our established CO 2 vasoreactivity protocol that included hyperventilation and CO 2 breathing. Overall, the vasoreactivity coefficient that was calculated from mean blood velocities in the right and left middle cerebral arteries (MCAR mean 0.610.88, MCAL-0.92 0.55 cm/s/mmHg) was lower in this population than generally observed for general population 1.29-1.340. 16 (Hajjar et al 2007) . Over the 6 months period there was a further decline of vasoreactivity, of an unclear clinical significance. In general, there were no significant changes in mean blood flow velocities and cardiovascular parameters over the intervention period, in those with improved vs. non improved A1C control. However, at 6 months there was a negative correlation between A1C change and systolic blood pressure and mean blood flow velocity, indicating an improvement of flow velocities and a decrease in blood pressure in response to hyperventilation.
Baseline mean blood flow velocities were also lower in this cohort of diabetic participants with hypertension (33.7±2.7cm/s), as compared to non-hypertensive diabetics (40.5±3.1cm/s) and non-diabetics controls ( 52.9± 3.3 cm/s) ( p<0.0001).
In addition, baseline mean velocities were also lower in those with very high A1C (> 8% 9.2±0.1, N=38) (32.9±3.5cm/s) as compared to diabetics with lower A1C levels (8-7%,7.42±0.1, N=23)(36.1±4.8 cm/s), low A1c (<7%,6.24±0.12, N=71) (41.7±3.2 cm/s) and controls with normal A1C (<5.7%, 5.35±0.1, N=34) (54.5±4.7cm/s) (p=0.0035).
In conclusion, in older diabetic patients blood flow declines significantly with uncontrolled diabetes (A1C.8%) and co-morbidities (hypertension and obesity).
We presented our interim data at the 68 th annual meeting of the American Diabetes Association. We are currently performing final analysis of the data preparing for a publication. The abstract is as follows.
Effects of Diabetes Mellitus on Cognitive Functions in olde r Adults: American Diabetes Association Scientific Sessions 2008
Background: Diabetes mellitus (DM) is a complex metabolic syndrome associated with microvascular disease and regional hypoperfusion. Specifically, it appears that the frontotemporal cortex that controls memory and decision making is the most sensitive to diabetic metabolic disturbance. We aimed to determine the effects of DM severity, co-morbidities, body mass index (BMI), and vascular inflammation on functional outcomes in older adults. Methods: We studied 34 subjects with type 2 DM (64.9±8.9yrs, 19 men and 15 women) and 28 healthy subjects (66.3±7.8yrs, 12 men and 16 women). Differential WBC, intracellular and vascular adhesion molecules (sICAM-1, sVCAM-1), TNF-a, IL-6, C-reactive protein (CRP) were measured. Gait speed was calculated from 12 min of hallway walking. Each subject performed a battery of neuropsychological tests to assess memory (Clock-in-the-Box; CIB, Hopkins Verbal Learning Test; HVLT, Rey-Osterreith Complex Figure; ROCF) and filled out questionnaires regarding depression (Geriatric Depression Scale; GDS) and activities of daily living (Instrumental Activities of Daily Living Scale; IADL). Data were analyzed using the least square models and ANOVA. Results: DM group had higher BMI (p=0.007), GDS (p=0.006), IADL (p=0.014), and TNF-a (p=0.006), and lower scores on measures of memory: CIB (p=0.005) and HVLT retention Tscores (p=0.039). Age, sex, mean blood pressure (MBP), ROCF, gait speed, CRP, and other immunoassays were not different between the groups. In both groups, BMI was positively associated with GDS (p=0.0002), and lower HVLT score was associated with increased MBP (p=0.01). IL-6 was negatively associated with CIB measures of memory (p=0.037), and higher values of IADL (p=0.016). Slower gait speed indicated higher IADL (p=0.019) and lower HVLT retention T-score (p=0.027). Among diabetic subjects, higher BMI was associated with higher GDS (p=0.0002) and higher HbA1c (p=0.003), and HVLT retention T-scores were negatively associated with MBP (p=0.004). Conclusions: Type 2 diabetes mellitus affects functions of short term memory and retention. High BMI and poor BP control are associated with worse DM control and functional outcomes of memory, depression and ability to perform daily activities.
Task 6: Analysis of data and information distribution. (Mos. 36-48): Joslin Clinic
We are now performing the final analysis of the longitudinal data and are in process of writing the manuscript. Our final abstract will be presented as poster in the upcoming scientific meeting of the American Diabetes Association On June 24 th 2011.
Age-specific Barriers Assessment and Intervention via Phone Improves Glycemic Control and Functionality in Older Adults: A Randomized Controlled Study.
The American Diabetes Association guidelines recommend the assessment of both age-specific barriers and geriatric syndrome to improve diabetes management in older adults. However, the impact of such a strategy on outcomes is unknown. Methods: We performed a randomized controlled study to evaluate the effect of assessment and intervention for age-specific barriers, implemented via phone communication between visits, on the glycemic control and other parameters in elderly subjects. Adults  69 years with A1C 8% were randomized to 3 groups; group 1: attention control (n=31) and groups 2 & 3: intervention (n=69). Intervention included assessment of barriers by a geriatric diabetes team and designing strategies to improve patients' ability to follow diabetes management plans as prescribed by their providers. The interventions were implemented via phone calls by an office-based diabetes educator in group 2 (n=34) and by a care manager in group 3 (n=35). The attention control subjects received equal number of "courtesy" phone calls by an educator. All subjects underwent measurement of glycemic control (A1C), functionality (Tinnetti and 6-minute walk test -6MW), self-care inventory-revised (SCI), and diabetesrelated distress (PAID). Results: We assessed 100 patients (age 755, duration 2113 years, 67 % with type-2, 89% on insulin). From baseline to 6-months, the glycemic control improved in the intervention groups but not in attention control. Similarly, the measures of functionality and SCI scores improved in intervention groups compared to control. The PAID score decreased in all 3 groups. Conclusion: Phone communication between clinic visits by an educator aware of age-specific barriers improves glycemic control and other outcomes in older adults with diabetes.
Changes from baseline to 6 months (Paired T-tests) Group 
Conclusion:
Our results show that phone contacts by a diabetes educator between the clinic visits to encourage management modifications based on patients ongoing barriers can improve diabetes control, functionality, and self-care, and reduce diabetes-related distress.
Our results are extremely significant as for the first time it identifies approach that may help improve diabetes control in the older adults and improve functionality that directly impacts quality of life. If our findings are confirmed in a larger study, this type of timely low cost intervention can prevent decline in patient's health and perhaps hospitalization and may provide basis for policy change for the best management of older patient with diabetes. This policy will especially be of benefit to the Veterans Hospitals as they have excellent structure already in place with availability of diabetes educators and geriatric specialists.
Other important observations from this study are as follows:
1. Older patients with diabetes have many challenges that prevent them from following their diabetes treatment properly. For example, if an elderly individual with diabetes gets sick or has a family emergency, his/her blood glucose may go too high or too low. A timely phone intervention by a diabetes educator can prevent further deterioration of the blood glucose and an adjustment in doses of medication/insulin can quickly regain better glucose control. Thus, helping older patients to overcome obstacles in taking medications, exercising and following diet can not only improve glucose control but also improve their gait and balance, ability to do day to day activity, stress related to diabetes, and ability to do self-care.
2. Older patients with even poor glucose control tend to get low blood glucose episodes. These low blood glucose episodes are not recognized by the patients and majority tend to occur at night between 10 pm and 6 am. Thus, low blood glucose episodes should be carefully looked for in all older patients with diabetes in spite of their glucose control.
3. The older patients who lack good social resources and support do worse not only with their glucose control, but also have poor exercise endurance and more frequent emergency medical visits. Thus, it is important to encourage good social safety net in elders with diabetes.
4. Older adults with diabetes make mistakes in insulin techniques even when they have been injecting the insulin for many years. Thus, older patients even with long duration of diabetes need periodical assessment and education regarding insulin injection techniques and medication compliance.
5.
Older patients who have high exercise capacity are able to manage their diabetes better. Thus, it is important to encourage exercise in all elders with diabetes. emergency department visits, and hospitalization. 4 Hypoglycemic episodes are difficult to diagnose in this population and are easily missed by intermittent finger-stick measurements. Recent large studies 5 have shown lack of benefit and sometimes higher risk of morbidity and mortality with tight glycemic control, especially in older adults. Therefore, the American Geriatric Society and the American Diabetes Association recommend relaxing glycemic control for vulnerable patients 6 (hemoglobin A 1C [HbA 1c ] Ͻ8% instead of the usual Ͻ7% [to convert HbA 1c levels to proportions of total hemoglobin, multiply by 0.01]). However, it is unknown whether relaxing the goal to an HbA 1c level of 8% or greater decreases the frequency of hypoglycemia in older patients remains unknown. Thus, we evaluated hypoglycemia in older diabetic patients with HbA 1c levels of 8% or greater with continuous glucose monitoring (CGM).
METHODS
Community-living patients 69 years or older seen at a tertiary care diabetes center with HbA 1c levels of 8% or greater were evaluated with blinded CGM (iPro; Medtronic, Inc, Northridge, California). The study was approved by the Committee on Human Subjects, and all patients provided written informed consent. Continuous glucose monitoring measured interstitial glucose levels at 5-minute intervals for a 3-day period in all patients while they continued their usual daily activities. Patients measured their glucose level by the finger-stick method 4 times a day while wearing CGM and recorded symptoms suggestive of hypoglycemia. Patients completed a demographics and treatment-related questionnaire, along with a modified clockdrawing test, 7 Geriatric Depression Scale, 8 Activities of Daily Living 9 and Instrumental Activities of Daily Living, 10 Six-Minute Walk Test, 11 Tinetti Test, 12 and Self-care InventoryRevised. 13 Continuous data are presented as mean (SD) when normally distributed and as median (range) when not normally distributed; frequency data are presented as number (percentage). Between-group differences in patient characteristics were compared with the Fisher exact 
We analyzed CGM data by measuring the following: (1) total number of hypoglycemic episodes (glucose level Ͻ70 mg/dL [to convert glucose to millimoles per liter, multiply by 0.0555]); (2) nocturnal hypoglycemic episodes (10 PM to 6 AM), which are dangerous because of patients' inability to recognize and treat them; (3) hypoglycemic episodes captured by CGM but unrecognized by finger-stick monitoring or symptoms; (4) duration (longer episodes are more dangerous); and (5) severity (glucose levels of Ͻ50, Ͻ60, and Ͻ70 mg/dL).
RESULTS
Forty patients 69 years or older were evaluated. Of these, 26 (65%) had at least 1 episode of hypoglycemia (median glucose level, 63 [range, 42-69] mg/dL) during the 3-day period. The groups with and without hypoglycemia did not differ in patient characteristics, comorbidities, exercise capacity, gait/balance, selfcare frequency, or diabetes-related stress (all P Ͼ.05) (Table) .
Among the 26 patients with hypoglycemia, 12 (46%) had an episode with glucose levels below 50 mg/dL, and 19 (73%) had an episode with levels below 60 mg/dL. The average number of episodes was 4, with an average duration of 46 minutes. Of a total of 102 hypoglycemic episodes, 95 (93%) were unrecognized by finger-stick monitoring or by symptoms. However, only 2 patients reported "hypoglycemia unawareness" in the questionnaire. Eighteen of the 26 patients (69%) experienced 1 or more nocturnal episodes (average duration, 56 minutes). No nocturnal episodes were recognized by patients.
We evaluated CGM results by levels of glycemic control (as evidenced by HbA 1c level) and type of diabetes in the 26 patients with hypoglycemia. Fourteen patients had HbA 1c levels between 8% and 9% and 12 had HbA 1c levels greater than 9%; the groups did not differ in the frequency (5.0 vs 2.7), duration (3.5 vs 2.4 hours), or severity (1.2 vs 1.1 episodes with glucose levels Ͻ50 mg/ dL) of hypoglycemic episodes or in the number of unrecognized episodes (2.5 vs 4.6). Similarly, 10 patients had type 1 and 16 patients had type 2 diabetes mellitus, and the groups did not differ in the frequency (4.3 vs 3.7), duration (3.2 vs 2.9 hours), or severity (1 vs 1.3 episodes with glucose levels Ͻ50 mg/ dL) of hypoglycemic episodes or in the number of unrecognized episodes (3.7 vs 3.6).
We also evaluated patient characteristics according to the severity of hypoglycemic episodes. The groups with patients who experienced no hypoglycemia, hypoglycemic episodes with glucose levels below 50 mg/dL, and hypoglycemic episodes with glucose levels between 50 and 70 mg/dL did not differ in age, type of diabetes, duration of diabetes, HbA 1c level, treatment with insulin, presence of comorbidities, or living status.
COMMENT
This study found an unexpectedly high frequency of hypoglycemic episodes in older adults with poor glycemic control. This finding is critical in the debate concerning glycemic goals in older adults. Current guidelines 6 based on expert opinions suggest relaxing HbA 1c goals to below 8% for vulnerable elders to avoid hypoglycemia-related morbidity. In the present study, 26 of 40 patients (65%) with HbA 1c levels of 8% or greater experienced 1 or more hypoglycemic episodes in a 3-day period. More important, 12 of the 26 patients with hypoglycemia experienced at least 1 episode of severe hypoglycemia (glucose level Ͻ50 mg/dL). These results suggest that simply relaxing HbA 1c goals may not be adequate to protect frail older adults against hypoglycemia.
In our study, not only patients with type 1 but also those with type 2 diabetes mellitus and poor glycemic control had frequent hypoglycemic episodes. This new information is important in considering recommendations of glycemic goals in the rapidly growing population of older adults with type 2 diabetes. We found that finger-stick glucose testing 4 times a day did not coincide with CGM-detected hypoglycemia. Most daytime episodes and all nighttime episodes were unrecognized both symptomatically and by finger-stick glucose monitoring. These results may partially explain the low incidence of hypoglycemia reported in previous studies. We did not ob- serve a difference in comorbidities and functionality between patients with and without hypoglycemia, perhaps because of the small sample size. The association between different classes of oral medications and/or various insulin regimens and the frequency of hypoglycemia will require larger studies. In a recent retrospective study, Munshi and colleagues showed that simplification of diabetes regimens in older adults with diabetes is associated with decreased frequency of selfreported hypoglycemia.
14 Further studies are needed to determine whether a simplified treatment regimen that better matches patients' selfcare abilities also improves hypoglycemic episodes detected by CGM. Our findings raise caution for relying on HbA 1c as the sole measure of "good diabetes management" in elderly patients with diabetes, and we recommend careful and in-depth assessment for hypoglycemia by both patients and providers. With aging, patients with diabetes face an increased incidence of multiple co-morbidities.
1,2 Some of the medical co-morbidities include cognitive dysfunction, depression, polypharmacy, and physical dysfunction. It is difficult for primary care providers to manage diabetes in patients who have a difficulty performing self-care and following a complicated treatment regimen. Even patients who are on an insulin regimen for a substantial period of time find it difficult to cope due to the added burden of co-morbidities. 3 Regimens with multiple insulin injections that require insight into the carbohydrateinsulin interaction as well as multiple finger-stick monitoring can lead to increased risk of complications such as hypoglycemia and associated falls. 4 Thus, older adults may benefit from a simplification of their regimen. The ability of patients who have longstanding diabetes and are on insulin treatment to respond to oral hypoglycemic agents remains unclear. In this study, we evaluate use of serum c-peptide levels to guide simplification of diabetes regimen.
RESEARCH DESIGN AND METHODS
We retrospectively analyzed all of the patients over the age of 65 years seen at a geriatric diabetes clinic from 2001 through 2006 in whom serum c-peptide levels were measured to identify those with endogenous insulin production. Serum c-peptide levels were measured in patients with either poor glycemic control or difficulty coping with insulin regimen. In patients with detectable serum c-peptide levels (Ͼ1.1 ng/mL; normal range 1.1-3.2 ng/mL), one or more oral hypoglycemic agents were added to simplify the regimen. Thioglitazone and metformin were used as insulin sensitizers in patients requiring large amounts of insulin. These medications were avoided in patients with co-morbidities that prohibit their use (eg, coronary artery disease, congestive heart failure, leg edema, renal failure). Insulin secretagogues (sulfonylurea and nonsulfonylurea compounds) were used in patients with low risk of hypoglycemia and were avoided in patients with erratic eating habits and hypoglycemic unawareness. If patients were unable to tolerate any oral hypoglycemic agents, we attempted to decrease the number of insulin injections (eg, changing the regimen from basal-bolus to mixed or longer-acting insulin twice a day). Medical and demographic information was collected from the chart.
We collected data on A1c measurements, as well as data on reports of hypoglycemic episodes at baseline and as available up to 4 consecutive visits over a period of up to 1 year following regimen change from the chart notes. Any episodes of hypoglycemia in the past 6 months were considered positive for the purpose of history. The study was reviewed by the committee on human subjects and was found to be exempt.
STATISTICAL METHODS
We calculated descriptive statistics and frequency distributions for all variables. Data are presented as mean Ϯ SD for continuous data and as n (%) for frequency data. The differences between clinical and demographic variables were compared between patient groups before and after simplification of regimen using the unpaired t test for discrete or continuous data and the chi-squared test for frequency distribution. Withingroup changes from baseline in A1c were analyzed using the t test for paired data. A value of P Ͻ.05 was considered to indicate statistical significance.
RESULTS
Sixty-five of 100 older adults had detectable serum c-peptide levels. The average age of these patients was 80 Ϯ 6 years (range 67-93 years), and 65% of the patients were women. Patients were taking 8.7 Ϯ 4 medications/day (range 3-16) and the mean duration of diabetes was 20.8 Ϯ 12.5 years (range 1-50 years). Thirty-seven of 65 patients reported hypoglycemic episodes during their office visit. The Table shows character- istics of patients with detectable serum c-peptide levels and patients who had successful simplification of regimen. The treatment regimen was not simplified in 19 of 65 patients with detectable c-peptide levels; 9 patients preferred to remain on insulin (did not want to add oral medications) and 10 patients were lost to follow-up before changes could be instituted. Of 46 patients available for simplification of regimen, 11 patients were unable to use oral hypoglycemic agents due to presence of multiple co-morbidities. Regimen was successfully modified in 35 patients. Metformin was added in 14 patients, sufonylurea was added in 16 patients, and thioglitazones were added in 19 patients. Twenty-three patients had one oral agent added, while 8 patients needed 2 oral agents and 4 patients were on 3 oral agents (median: 1 oral agent/patient; range: 1-3). Of these, the insulin therapy in 19 patients was completely discontinued and patients were maintained only on oral hypoglycemic agents. In the other 16 patients, an oral hypoglycemic agent was added and the number of daily insulin injections was decreased from an average of 2.7 Ϯ 1 to 1.5 Ϯ 0.8 injection/day (P ϭ .001). In 3 of the patients, glycemic control deteriorated on oral medications, and once-daily long-acting insulin was added.
CLINICAL SIGNIFICANCE
• Older adults with long duration of diabetes, on insulin therapy, may have preserved endogenous insulin production as seen by detectable serum c-peptide level.
• Serum c-peptide levels can be used to guide simplification of the diabetes regimen in older adults who have difficulty coping with a complicated insulin regimen.
• The simplification of the diabetes regimen may lead to reduced risk of hypoglycemia without compromising glycemic control. Among the 35 patients whose regimen was simplified, initial A1c, before change in the regimen, was 8.0% Ϯ 1.5%, compared with 8.1% Ϯ 1.4% in patients whose regimen could not be simplified. In patients with simplified regimen, we evaluated the excursion of A1c as available during 4 consecutive visits over a period of up to 1 year following addition of oral hypoglycemic agents (Figure) . The number of subjects at the initial A1c measurement was 35, and the subsequent measurements were 32, 27, 22, and 18, respectively. A1c improved from a pre-intervention level of 8.0% Ϯ 1.5 % to 7.4% Ϯ 1.5% at the lowest level (P Ͻ .002). In 3 patients, follow-up A1c was not available after the changes were made. Although this was not a randomized study, the patients whose regimen was not simplified had their A1c change from 8.1% Ϯ 1.4% initially to 7.8% Ϯ 1.4% at the lowest level (P ϭ not significant).
Eleven of these patients had A1c Ͼ8%, while 22 patients had A1c Յ8% at the time of serum c-peptide measurement. Following modification of the regimen, improvement in A1c was observed in the group with high A1c (9.3% Ϯ 1.5% to 8.2% Ϯ 1.8%; P Ͻ .0001); while in the group with lower A1c, the favorable A1c was maintained (7.0% Ϯ 0.8% to 6.9% Ϯ 1%; P ϭ not significant).
Before simplification of the regimen, 22 of 35 patients reported episodes of hypoglycemia during their office visit. Following simplification of the therapy, report of hypoglycemic episodes significantly decreased, with only 2 patients reporting such episodes.
DISCUSSION
This study shows that a majority of older adults with long duration of diabetes have preserved endogenous production of insulin. In addition, we have shown successful utilization of detectable serum c-peptide levels to simplify treatment regimen. Such change in the study population decreased the reported episodes of hypoglycemia, and maintained or improved their glycemic control.
Many older adults have long duration of diabetes and were started on insulin regimen early on. Although most older patients have type-2 diabetes, primary care providers usually feel uncomfortable trying oral medications in patients with long duration of diabetes and face difficulties in patients who are unable to perform self-care. In recent years, with the introduction of new oral hypoglycemic agents, more options are available. [5] [6] [7] However, there is currently a lack of data about the type of patient that can be safely converted to a simpler regimen or an effect of the change on glycemic control. Serum c-peptide levels can be used as a simple tool in such situations. Due to the retrospective nature of the current study, it is not possible to attribute the improvement in A1c to regimen change; however, it was reassuring to see that glycemic control did not deteriorate after simplification. It is likely that improvement in A1c seen in patients with simplified regimen is due to their ability to better cope with the simplified treatment.
A major concern for older adults with diabetes is the risk of hypoglycemia. In a recent study, older patients on insulin had a higher risk of falls with tighter control. 8 Falls lead to fractures and decreased functionality, directly affecting quality of life in this age group. 9 If a simplification of regimen can lower the risk of hypoglycemia as shown in this study, it may lead to significant cost-saving and improvement in quality of life.
The limitation of this brief report is its retrospective nature. However, this is an important observation and provides rationale for future prospective randomized studies to develop specific protocols and guidelines to simplify diabetes regimen in older adults. Figure A1c at the initial visit, at the lowest level, and at up to 4 consecutive visits in 1 year following simplification of regimen. *P Ͻ.002.
Cognitive and Psychosocial Aspects of Caring for Elderly Patients With Diabetes
Isao Iwata, MD, PhD, EdM, and Medha N. Munshi, MD Introduction Diabetes is a major cause of morbidity and mortality among older adults. The current prevalence of diabetes among adults 65 years of age or older is 15.3%, and 6.9% of additional individuals are thought to have undiagnosed diabetes [1•] . The group of adults with diabetes who are 75 years of age and older is the fastest growing population among all age groups with diabetes [2] . Older adults with diabetes have multiple coexisting conditions and some of them interfere with patients' ability to perform self-care. Dementia/cognitive dysfunction and depression/depressive mood are such conditions found commonly in older adults with diabetes [3] [4] [5] [6] . The association between diabetes and these conditions has been studied for the past several decades through epidemiologic analyses and pathophysiologic investigations.
In this article, we review recent literature on epidemiology and clinical aspects of cognitive and psychosocial dysfunction in older patients with diabetes mellitus, focusing on the cognitive dysfunctions, dementia, depression, and depressive mood disorders. We also review the relevance of these cognitive and psychosocial problems on clinical management of diabetes in older patients.
Cognition and Diabetes
Cognitive impairment and diabetes
Several clinical studies have shown that diabetes is associated with cognitive impairment, and that the presence of diabetes accelerates cognitive decline in older adults [6] [7] [8] [9] . Multiple case-control studies have assessed cognitive dysfunction using various batteries of neuropsychiatric testing. Some of these studies also assessed whether specifi c areas of cognitive function were affected by diabetes. Stewart and Liolitsa [6] summarized more than 20 case-control studies and found that the defi cit in the attention/concentration domain and verbal fl uency among patients with diabetes appeared to be consistent. However, the authors thought that the reliability of the case-control studies was somewhat questionable due to inadequate control for potential confounding factors, such as hypertension and depression. In addition, because of smaller sample size, typically involving 30 to 40 individuals, some case-control studies did not have enough power to detect small differences in cognitive function tests, leading to confl icting results.
Following the case-control studies above, several population-based studies investigated the possibility of preferential defects in cognitive function among the population with diabetes [8, 10, 11] . These population-based cohort studies included a large number of prescreened individuals and followed them prospectively. The Framingham study observed 187 patients with type 2 diabetes and 1624 individuals without diabetes for 28 to 30 years [10] . The authors found that type 2 diabetes was associated with a 1.8-fold increase in the risk of poor performance in visual memory in patients who also had hypertension. The longer duration of diabetes I Iwata and Munshi I 141 was associated with an increased risk of poor performance in verbal memory and concept formation in the patients with diabetes. Arvanitakis et al. [11] followed 824 older Catholic nuns, priests, or brothers for a mean of 5.5 years and found that diabetes was associated with a 44% greater rate of decline in perceptual speed but not in other cognitive systems. In a recent population-based cross-sectional study, 882 older patients without dementia were enrolled. The results showed that diabetes was associated with poor semantic memory and perceptual speed controlling for age, sex, and education, although the association of diabetes with perceptual speed was not signifi cant when controlling for vascular variables, such as congestive heart failure, current smoking, and systolic and diastolic blood pressure [12] . A recent cross-sectional study of homebound older people by Qiu et al. [13•] showed that older people with diabetes scored signifi cantly lower in visuospatial functions and executive functions compared to peers without diabetes (Block Design test mean score ± SD, 17.1 ± 8.6 vs 20.5 ± 9.6; P = 0.003; Trail Making Part B test median seconds to accomplish the task, 255 vs 201; P = 0.03).
A series of longitudinal cohort studies also have shown diabetes as a strong risk factor for cognitive decline (Table 1) [14] [15] [16] . In these studies, diabetic subjects had greater risk for cognitive decline as measured by scores on selected neuropsychological test battery, with odds ratios of 1.3 to 1.7. These longitudinal cohort studies typically used two to fi ve different cognitive tests, but the main conclusions were often drawn from the composite scores of multiple tests. Frequently used cognitive tests that have produced a statistically signifi cant difference between subjects with and without diabetes include the following: Digit-Span [8, 14] , Delayed Word-List Recall [9, 14] , Trail Making Part B test [7, 17, 18] , Auditory Verbal Learning test [7] , and Digit Symbol test [7, 8, 18] . Many studies found no signifi cant change in scores on the Mini-Mental State Examination (MMSE) or modifi ed MMSE [7, 18] , with a few exceptions [9] , suggesting that MMSE may not have enough sensitivity to capture the difference in cognitive decline in a relatively short period of time (2-4 years). For assessing global cognitive function, Telephone Interview for Cognitive Status, which was modeled on MMSE, was used in the Nurses' Health Study, Women's Health Study, and Physicians' Health Study and appeared to be quite sensitive [14, 15] . In older adults with diabetes, coexisting hypertension was associated with accelerated decline in cognitive and physical function [19, 20] . In summary, cognitive dysfunction is commonly associated with diabetes in older adults.
Glycemic control and cognitive dysfunction
Several longitudinal studies have found that longer duration of diabetes and treatment with insulin are independently associated with a higher risk of cognitive dysfunction. Due to scarce sampling of glucose level and unavailability of the value of hemoglobin A 1c (HbA 1c ), the relationship of cognitive function and glycemic control was not addressed in those large population studies. However, in a smaller study, Munshi et al. [21•] reported that the cognitive dysfunction was associated with poor glycemic control in older adults. Similarly, van Harten et al. [22] showed that the duration of diabetes was associated with the domain motor speed in 92 older adults with type 2 diabetes. They also found that higher HbA 1c was associated with global cognitive dysfunction, using the HIV Dementia Scale [22] . Perlmuter et al. [23] also reported that cognitive performance was poorer in diabetic patients with elevated HbA 1c levels, and the authors suggested that signifi cant cognitive impairment might complicate adherence to treatment regimen.
Some clinical trials have shown that improving glycemic control may lead to cognitive improvement in a few domains. Ryan et al. [24] showed that after 24 weeks of treatment with glyburide or rosiglitazone, working memory improved in the two treatment groups. Although such fi ndings may suggest reversible cognitive dysfunction secondary to hyperglycemia or hyperinsulinemia, other studies suggest that most of the cognitive impairment would accumulate over time and result in irreversible structural abnormality in the brain [22] .
Thus, growing evidence exists that cognitive dysfunction is associated with poor glycemic control. However, more studies are needed to assess whether improved glycemic control can lead to improved cognitive function.
Vascular dementia, Alzheimer's disease, and diabetes
Diabetes is a major risk factor for cardiovascular diseases, and is strongly associated with the development of vascular dementia that is due to macro-and/or micro-cerebrovascular angiopathy. Alzheimer's disease, a progressive brain disorder with gradually developing memory loss, inability to learn, reason, make judgments, communicate, and perform daily activities, is the most common form of a degenerative type of dementia in the United States [25] . The association of Alzheimer's disease with diabetes is not well established [26, 27] .
A meta-analysis of fi ve prospective observational studies looking at the risk of all causes of dementia in patients with diabetes showed that the overall risk for developing future dementia was 1.6-fold (95% CI, 1.4-1.8) in patients with diabetes compared to those without diabetes [28] . Although patients with diabetes had a 2.2-to 3.4-fold higher risk of developing vascular dementia, the reported risk of developing Alzheimer's disease was somewhat smaller at 1.2-to 2.3-fold. This discrepancy was thought to be due to different diagnostic criteria used in these studies for Alzheimer's disease and for diabetes. Another limitation of these longitudinal studies is the lack of detailed clinical information on diabetes, such as glycemic control, treatment modality, and diabetic complications [11, 26, 27] . The possible mechanisms of association between diabetes, cognitive dysfunction, and dementia have been discussed and summarized in recent review articles [25] . Some of the mechanisms include direct toxicity of chronic hyperglycemia through various pathways (advanced glycation end product, polyol pathway, oxidative stress, amyloid deposition), involving different targets (blood vessels and white matter). Hyperinsulinemia is reported as another risk factor of Alzheimer's dementia because insulin may impair the clearance of amyloid β in the brain [29] . Thus, diabetes increases risk of dementia in older adults mediated by various mechanisms.
Psychosocial Aspects
Depression and diabetes
Depression and diabetes are common conditions among older adults. Based on the assessment methods used, the prevalence of depression in elderly patients with diabetes varies. In a large study by Bell et al. [3] , 21.0% of older Native Americans were found to have depressive symptoms, whereas 14.6% of older African Americans and 13.6% of white Americans had depressive symptoms. A meta-analysis of 39 studies demonstrated that major depression and elevated depressive symptoms were present in 11% and 31% of individuals with diabetes, and that the prevalence of depression was higher in subjects with diabetes than in those without diabetes (OR = 2.0; 95% CI, 1.8-2.2) [30] . Studies also have shown that having depressive symptoms is a risk factor for developing type 2 diabetes [31] and that diabetes is associated with increased risk of depressive symptoms [32•] ; thus, the association between diabetes and depressive symptoms is likely to be bidirectional [33•] .
A meta-analysis by Lustman et al. [5] included 26 cross-sectional studies that assessed the association between glycemic control and depression. The authors showed that depression was signifi cantly associated with higher glycohemoglobin, with the standardized effect size of 0.17, which was in the small-to-moderate range [5] . In another study, Maraldi et al. [32•] reported that among 70-to 79-year-old persons, the risk of depression and depressive mood was especially higher in those with poor glycemic control.
Depression in older patients with diabetes has a significant impact on patients' mortality [34] , quality of life [35] , and the health care costs to society [36] . In a 3-year prospective cohort study, Katon et al. [34] showed that older patients with diabetes and minor depression had a 1.7-fold increase in mortality and those with major depression had a 2.3-fold increase in the risk of mortality compared to patients without depressive symptoms. Patients with diabetes and depression had signifi cantly lower scores in every dimension of the Short-Form Health-Related Quality-of-Life Questionnaire (SF-36) than those with diabetes but no depression [35] . Among Medicare patients with diabetes, major depression was associated with 21% greater annual nonmental health-related payments than those without major depression [36] .
For patients with diabetes and depression, treatment with cognitive behavioral therapy [37] and selective serotonin reuptake inhibitors [38, 39] has been used successfully to manage symptoms. Interestingly, the fl uoxetine treatment group in this study [38] had greater improvement in mean glycohemoglobin level. However, the difference did not reach statistical signifi cance, partly because of relatively short treatment periods (8 weeks) [38] . Sertraline's effi cacy also has been tested in clinical trials in patients with diabetes and major depressive disorders. In the trial comparing sertraline with placebo as maintenance treatment for those who achieved depression recovery with open-label sertraline treatment, the 1-year nonrecurrence rate was 66% in the sertraline group compared with 47.9% in the placebo group [39] . The clinical trial showed signifi cant improvement in HbA 1c after 8 weeks of induction therapy. At the end of the randomized period, however, no difference in glycemic control occurred between the sertraline group and the placebo group, although HbA 1c remained low in the two groups [39] . Another interesting fi nding in this study was that younger age was an independent predictor of depression recurrence. The secondary analysis by Williams et al. [40] demonstrated that sertraline was not effective in preventing recurrence of depression in patients 55 years of age or older. Bogner et al. [41] conducted a multisite, practice-randomized control trial to assess the effi cacy of a primary care-based depression management program for depressed patients with diabetes. They found a 51% decrease in mortality (95% CI, 2-76) in the intervention group during the 5-year follow-up. The data on glycemic control were not available in this study.
Thus, diabetes and depression have a bidirectional relationship with increased risk. Depression treatment can be successful in patients with diabetes, although its affect on glycemic control remains unclear.
Other psychosocial aspects and diabetes
Diabetes self-management imposes specifi c physical and emotional burdens on patients with diabetes. Delahanty et al. [42] studied the affect of treatment of diabetes on the Problem Areas in Diabetes (PAID), a 20-item selfreport measure of diabetes-related emotional stress. The results showed that PAID scores were signifi cantly higher among insulin-treated patients compared with patients on oral hypoglycemic agents or those treated with diet alone. The two most serious problems among PAID items were "worrying about the future" and "guilt/anxiety when… off track with diabetes." Higher PAID scores (ie, greater emotional distress) were correlated with younger age, nonwhite race ethnicity, female gender, higher HbA 1c , higher 144 I Psychosocial Aspects body mass index, and treatment type. Nakahara et al. [43] investigated the causal relationship between HbA 1c and psychosocial factors captured by the Multi-Dimensional Diabetes Questionnaire. A survey was conducted on 256 Japanese adults with type 2 diabetes (mean age, 62 years) observed at a medical center. The study results showed that self-effi cacy directly reinforced adherence, and better adherence was associated with better glycemic control measure at follow-up HbA 1c . A qualitative research conducted by Schoenberg and Drungle [44] highlighted that psychosocial barriers to diabetes management among older adults with diabetes included fi nancial challenges, lack of access to quality care for diabetes, and pain and disability that inhibit self-care behaviors.
In general, very old or frail elderly patients with diabetes are likely to lose physical, mental, or psychosocial independence, which requires signifi cant involvement of caregivers in diabetes management. Caregiver stress is one area that needs to be addressed in future research. An evaluation of the social and fi nancial support system for all older patients with diabetes should be assessed.
Relevance to Diabetes Care
Coexisting medical comorbidities are important to recognize as barriers to good glycemic control in older adults with diabetes. Cognitive dysfunction, depression, and other psychosocial issues can lead to not only poor control but also lower quality of life and increased caregiver needs, leading to higher medical expenditure in care of these patients. The All Wales Research into Elderly diabetes study found that patients with diabetes and cognitive dysfunction (MMSE score < 23) were less independent and less likely to be involved in diabetes self-care and monitoring [45] . A low MMSE score was also associated with reduced activities of daily living, and increased need for assistance in personal care. Depression also poses a great challenge in managing diabetes among older adults. Lin et al. [46] showed that major depression was associated with less physical activity, unhealthy diet, and lower adherence to medications.
Thus, it is important to 1) screen all older patients with diabetes periodically for cognitive dysfunction, depression, and other psychosocial stresses in the clinical practice; 2) individualize the management goals and plans based on the barriers when identifi ed; and 3) optimize cardiovascular risk factors to lower the risk of vascular dementia.
Screening for psychosocial barriers
The presence of cognitive dysfunction and depressive symptoms is frequently overlooked in the care of elderly patients. It is essential to recognize early signs of cognitive decline and subtle symptoms of depression using appropriate screening tools [4] .
Cognitive function screening should cover global cognitive functions, including memory and executive function.
However, the tools need to be short and easy to use in a clinical practice. MMSE is a useful screening tool that covers orientation, registration, attention, recall, language, and praxis. However, MMSE is not a sensitive test to measure executive dysfunction, which presents with subtle symptoms. The clock drawing test is another commonly used screening tool for cognitive dysfunction especially affecting executive functions. Participants are asked to draw a clock face on a paper and place the hour and the minute hands at a set time [21•,45] . Because any type of cognitive assessment relies heavily on the ability to listen, read, and write, it is important to take into account any physical disability (vision, hearing, and dexterity), education, and literacy level, and the language barrier for non-native speakers.
For depressive symptoms, the 15-item Geriatric Depression Scale is a reliable and commonly used tool [4,21•] . A total score above 5 suggests depressive symptoms. It is also important for clinicians to look for reversible conditions that may cause or exacerbate cognitive dysfunction and/or depressive symptoms, such as hypothyroidism, infections, metabolic abnormalities, and delirium [4] . PAID can be used for assessing diabetes-related emotional distress, although its negative correlation with age may raise questions about its sensitivity in elderly persons [42] .
Individualized management for patients with diabetes and cognitive and psychosocial problems
Cognitive impairment, depression, and other psychosocial issues may interfere with the older patients' ability to perform self-care. These conditions may present as nonadherent to medical treatment or as sudden deterioration of glycemic control with no obvious causes. In each individual case, health care providers must identify unique problems and barriers in physical, cognitive, and psychosocial aspects. Depression and depressive symptoms should be treated promptly by medical therapy and/or cognitive behavioral therapy. When elderly patients exhibit signifi cant cognitive impairment, referral to specialists for detailed neuropsychiatric evaluation may help patients and caregivers deal with this chronic and often progressive neuropsychiatric disorder. Physicians should accommodate therapeutic modality to patients' cognitive and physical capacity, and may need to change the target glycemic control to minimize the risk of hypoglycemia. A multidisciplinary team approach-clinical diabetes educators, dietitians, clinical pharmacist, social worker, endocrinologists, and primary care providers-can help improve the care for older adults with diabetes.
Optimize cardiovascular risk factors to prevent vascular dementia
A randomized control study showed that blood pressure-lowering treatment with perindopril and indapamide (mean follow-up, 3.9 years) was associated with reduced risk of dementia and cognitive decline (relative risk, 19% [47] . Cholesterol lowering with statins also may be benefi cial for preventing cognitive impairment [48] . However, no randomized clinical trials have tested the effi cacy of diabetes treatment on preventing cognitive impairment and dementia. Two trials were found in clinical trial registry (http://ClinicalTrials.gov). One uses metformin for overweight persons 50 to 90 years of age and assesses the change in cognitive function in 12 months (ClinicalTrials.gov Identifi er: NCT00620191). The other trial is the ACCORD-MIND (Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes) (ClinicalTrials.gov Identifi er: NCT00182910) [49] . In this trial, the primary aim is to test whether there is a difference in cognitive decline and structural brain change in patients with diabetes who were treated with standard care compared with those treated with intensive care (target HbA 1c < 6.0%). Although this study will provide further insight into the association of diabetes and cognitive dysfunction, its ambitious glycemic control target (HbA 1c < 6%) may hinder a favorable effect on maintaining cognitive function by increasing clinical or subclinical hypoglycemia.
Conclusions
In older adults, cognitive impairment and depression are prevalent and strongly associated with diabetes. Diabetes is a major risk factor for developing cognitive dysfunction and vascular dementia. The association between diabetes and depression is bidirectional: diabetes increases the risk of depression and depressive symptoms, and patients with depression have a higher incidence of new-onset diabetes. Depression in older adults with diabetes can be treated successfully with selective serotonin reuptake inhibitors and cognitive behavioral therapy, and remission of depressive symptoms with antidepressant may lead to improved glycemic control. Because signifi cant cognitive decline has been seen in elderly patients with diabetes and hypertension, optimizing cardiovascular risk factors is important for preventing cognitive deterioration in older patients with diabetes. Whether better glycemic control alleviates depressive symptoms or prevents cognitive impairment remains to be seen in forthcoming clinical trials. It is imperative for health care providers to periodically screen older patients with diabetes for cognitive dysfunction, depression, and other psychosocial stresses to individualize the management goals and plans.
